SCHEMBL8805728

SCHEMBL8805728

Cc1cc2c(cc1N1CCC(O)CC1)CCC(=O)N2

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 5/20 0.44
▸ HTT P42858 4/20 0.44
▸ MAPT P10636 3/20 0.44
▸ TSHR P16473 2/20 0.44
▸ USP2 O75604 2/20 0.44
▸ PKM P14618 5/20 0.43
▸ MAPK1 P28482 2/20 0.39
▸ DRD2 P14416 2/20 0.39
▸ CRBN Q96SW2 3/20 0.38
▸ SMN1; SMN2 Q16637 4/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ CA9 Q16790 1/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ MMP12 P39900 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ PDE3B Q13370 1/20 0.35
▸ PDE3A Q14432 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8808373 0.84 DRD2 (0.39) LMNAHTTMAPTTSHRUSP2
SCHEMBL8805609 0.84 HSP90AA1 (0.37) LMNAHTTMAPTTSHRUSP2
SCHEMBL8805822 0.84 LMNA (0.42) LMNAHTTMAPTTSHRUSP2
SCHEMBL8805823 0.82 CRBN (0.44) HTTMAPTPKMDRD2CRBN
SCHEMBL8806081 0.81 DRD2 (0.42) LMNAHTTMAPTPKMDRD2
SCHEMBL8805973 0.81 PDE3B (0.43) LMNAHTTMAPTDRD2SMN1; SMN2
SCHEMBL8806549 0.80 MAPT (0.51) LMNAHTTMAPTTSHRALDH1A1
SCHEMBL8807339 0.76 SLC6A4 (0.52) CRBNALOX15NPC1PDE3BPDE3A
SCHEMBL8805021 0.70 CRBN (0.39) TSHRPKMDRD2CRBNALDH1A1
SCHEMBL8806234 0.68 HSP90AA1 (0.37) LMNAHTTMAPTTSHRUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0583136-B1 Piperidino-3,4-dihydrocarbostyryl compounds for the treatment of ischemic disorders KISSEI PHARMACEUTICAL (JP) 1997-10-08 — — EP disclosed
US-5294718-A Platelet aggregation inhibitors; antiischemic agents; side effect reduction KISSEI PHARMACEUTICAL CO., LTD. (JP) 1994-03-15 — — US disclosed
EP-0583136-A2 Piperidino-3,4-dihydrocarbostyryl compounds for the treatment of ischemic disorders Kissei Pharmaceutical Co., Ltd. (JP) 1994-02-16 — — EP disclosed
Send feedback